Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (841-850 of 955) with videos related to

Pageof 96
Sort By:
Blood|September 20, 2002
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of HematologyJ Douglas Rizzo, Alan E Lichtin, Steven H Woolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of HematologyJ Douglas Rizzo, Alan E Lichtin, Steven H Woolf, et al.
Cancer Medicine|August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trialLaurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
JAMA|October 23, 2003
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialMark G Kris, Ronald B Natale, Roy S Herbst, et al.
Journal of the American Heart Association|October 17, 2022
Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODYAntonio Brucato, Michelle Z Lim-Watson, Allan Klein, et al.
The Prostate|May 10, 2022
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805Alicia K Morgans, Yu-Hui Chen, David F Jarrard, et al.
Blood Advances|May 5, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national studyGregory A Abel, Donnie Hebert, Cecilia Lee, et al.
Neurology|March 13, 2013
Emotion assessment using the NIH ToolboxJohn M Salsman, Zeeshan Butt, Paul A Pilkonis, et al.
Implementation Science Communications|November 29, 2023
The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel methodJustin D Smith, Wynne E Norton, Sandra A Mitchell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2023
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 TrialNathaniel S O'Connell, Fengmin Zhao, Ju-Whei Lee, et al.
Pageof 96

Showing results (841-850 of 955) with videos related to

Sort By:
Pageof 96
Blood|September 20, 2002
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of HematologyJ Douglas Rizzo, Alan E Lichtin, Steven H Woolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of HematologyJ Douglas Rizzo, Alan E Lichtin, Steven H Woolf, et al.
Cancer Medicine|August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trialLaurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
JAMA|October 23, 2003
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialMark G Kris, Ronald B Natale, Roy S Herbst, et al.
Journal of the American Heart Association|October 17, 2022
Interleukin-1 Trap Rilonacept Improved Health-Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODYAntonio Brucato, Michelle Z Lim-Watson, Allan Klein, et al.
The Prostate|May 10, 2022
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805Alicia K Morgans, Yu-Hui Chen, David F Jarrard, et al.
Blood Advances|May 5, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national studyGregory A Abel, Donnie Hebert, Cecilia Lee, et al.
Neurology|March 13, 2013
Emotion assessment using the NIH ToolboxJohn M Salsman, Zeeshan Butt, Paul A Pilkonis, et al.
Implementation Science Communications|November 29, 2023
The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel methodJustin D Smith, Wynne E Norton, Sandra A Mitchell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2023
Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 TrialNathaniel S O'Connell, Fengmin Zhao, Ju-Whei Lee, et al.
Pageof 96